Levels of Evidence Needed for Changing Indications, Contraindications, and Food and Drug Administration Labeling: The Case of Metformin
Dean T. Eurich, BSP, PhD, Sumit R. Majumdar, MD, MPH, Finlay A. McAlister, MD, MSc, Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, Jeffrey A. Johnson, PhD
Arch Intern Med. 2011;171(11):1042-1043.
Published online June 13, 2011
Select Pricing Criteria:
Choose criteria for pricing info
Want online access for an institution? Learn More/Request Quote >